Llwytho...
GUCY2C-targeted cancer immunotherapy: past, present and future
For the last decade we have focused on guanylyl cyclase C (GUCY2C) as a potentially ideal target antigen for colorectal cancer immunotherapy. GUCY2C is expressed only in intestinal epithelial cells and by nearly 100% of colorectal cancers. We have developed and tested a recombinant adenoviral vector...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Immunol Res |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6892460/ https://ncbi.nlm.nih.gov/pubmed/22038530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12026-011-8253-7 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|